By adhering to ICH guidelines, pharmaceutical companies can ensure that their products are safe and effective, which directly benefits cancer patients. These guidelines facilitate quicker approval times for new treatments, reduce the likelihood of adverse effects, and ensure that clinical trials are conducted ethically.
